SCHEMBL27615907

SCHEMBL27615907

Cc1cc(NC(=O)O)c(NC(=O)CC(=O)c2cccc(-c3ccc(C(C)C)nc3)c2)cc1Cl

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.40
ALDH1A1 P00352 3/20 0.40
NPC1 O15118 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
MAPT P10636 2/20 0.38
MAPK1 P28482 1/20 0.38
NR1H4 Q96RI1 2/20 0.35
LMNA P02545 1/20 0.35
LIFR P42702 1/20 0.35
ABL1 P00519 1/20 0.35
BCR P11274 1/20 0.35
S1PR1 P21453 1/20 0.34
S1PR3 Q99500 1/20 0.34
ERCC5 P28715 2/20 0.34
FEN1 P39748 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5557504 0.89 AAK1 (0.37) RAB9AALDH1A1NPC1SMN1; SMN2MAPT
SCHEMBL27615901 0.87 RAB9A (0.41) RAB9AALDH1A1NPC1SMN1; SMN2MEN1
SCHEMBL27597124 0.86 POLB (0.41) RAB9AALDH1A1MEN1KMT2AABL1
SCHEMBL27615862 0.84 RAB9A (0.39) RAB9AALDH1A1NPC1SMN1; SMN2MEN1
SCHEMBL27597107 0.83 MEN1 (0.46) ALDH1A1MEN1KMT2A
SCHEMBL27615869 0.82 WNT3A (0.44) RAB9AALDH1A1NPC1SMN1; SMN2MEN1
SCHEMBL27615835 0.82 WNT3A (0.44) RAB9AALDH1A1NPC1SMN1; SMN2MEN1
SCHEMBL27597164 0.81 ALDH1A1 (0.45) RAB9AALDH1A1NPC1SMN1; SMN2MEN1
SCHEMBL27597134 0.79 RAB9A (0.42) RAB9AALDH1A1NPC1SMN1; SMN2MEN1
SCHEMBL27615899 0.79 RAB9A (0.42) RAB9AALDH1A1NPC1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100497333-C Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders HOFFMANN LA ROCHE (CH) 2009-06-10 CN disclosed
CN-1633430-A Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders HOFFMANN LA ROCHE (CH) 2005-06-29 CN disclosed